Vés al contingut

Comparison of treatment completion rates with three short-course rifamycin-based regimens (three months of daily isoniazid plus rifampicin [3HR], three months of once-weekly isoniazid plus rifapentine [3HP], and four months of daily rifampicin [4R]) for treatment of latent tuberculosis infection in patients with end-stage kidney disease: A randomised controlled clinical trial]

Obert
  • Codi protocol: PI21/004444
  • Codi EudraCT: 2021-003995-15
  • Grup de recerca: Pneumologia
  • Servei: Pneumologia
  • Investigador/a principal:  De Souza Galvao, Maria Luiza
  • Malaltia: Malalties del sistema respiratori
  • Fase: Fase IV
  • Estat: Reclutant voluntaris